January Social Media Round-Up—Celebrating 175, Discussing AI, and Attending CES 2024
One month into the new year and Pfizer is already got plenty to show for it.
January’s social media round-up features a dispatch from Las Vegas’s CES conference, our CTO’s insight into artificial intelligence’s impact on cancer, and an impassioned pleas from our CEO.
Catch up below:
CEO Albert Bourla kicks off Pfizer’s 175th anniversary celebration:
Chief People Experience Office Payal Sahni Becker celebrates Pfizer’s inclusion on Fortune’s Most Admired Companies list:
https://www.linkedin.com/feed/update/urn:li:activity:7159211335610699776/
CEO Albert Bourla TIME Op-Ed urging action for Israeli hostages in Gaza:
Chief Marketing Officer Drew Panayiotou reports back on his experience at CES 2024:
https://www.linkedin.com/posts/drewpanayiotou_ces2024-ai-activity-7151732623998930944-45mi
CEO Albert Bourla lists some of the company’s 2023 highlights:
https://www.linkedin.com/posts/albert-bourla_pfizerproud-activity-7158185661068427266-WWcI
Chief Digital and Technology Officer Lidia Fonseca shares her discussion with Forbes about AI’s impact on healthcare and the future of cancer treatment:
https://www.linkedin.com/feed/update/urn:li:activity:7159219986593386496
05.01.2024 Albert Bourla Cancer Covid-19 Diversity & Inclusion Leadership Vaccines April Social Media Round-Up—Black Maternal Health, World Immunization, and Long Covid 04.30.2024 Cancer Covid-19 Leadership Technology Pfizer Goes Live in SXSW’s Podcast Lounge 04.09.2024 Albert Bourla Cancer Diversity & Inclusion Leadership March Social Media Round-Up—Annual Review, International Women’s Day, and a School of Science Celebration 04.05.2024 Breast Cancer Cancer Research Working to “Outdo” Cancer: A Multi-Modality Approach to Accelerating the Next Generation of Cancer Breakthroughs 03.27.2024 Health Equity Partnerships Rare Diseases Pfizer Teams With Black British Choir to Bring Awareness to Sickle Cell, Rare Diseases